• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于拉曼光谱的无标记循环游离 DNA 分析进行人类疾病特征分析。

Label-Free Human Disease Characterization through Circulating Cell-Free DNA Analysis Using Raman Spectroscopy.

机构信息

Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, 70013 Heraklion, Greece.

Department of Industrial Design and Production Engineering, University of West Attica, 12244 Athens, Greece.

出版信息

Int J Mol Sci. 2023 Aug 3;24(15):12384. doi: 10.3390/ijms241512384.

DOI:10.3390/ijms241512384
PMID:37569759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10418917/
Abstract

Circulating cell-free DNA (ccfDNA) is a liquid biopsy biomaterial attracting significant attention for the implementation of precision medicine diagnostics. Deeper knowledge related to its structure and biology would enable the development of such applications. In this study, we employed Raman spectroscopy to unravel the biomolecular profile of human ccfDNA in health and disease. We established reference Raman spectra of ccfDNA samples from healthy males and females with different conditions, including cancer and diabetes, extracting information about their chemical composition. Comparative observations showed a distinct spectral pattern in ccfDNA from breast cancer patients taking neoadjuvant therapy. Raman analysis of ccfDNA from healthy, prediabetic, and diabetic males uncovered some differences in their biomolecular fingerprints. We also studied ccfDNA released from human benign and cancer cell lines and compared it to their respective gDNA, confirming it mirrors its cellular origin. Overall, we explored for the first time Raman spectroscopy in the study of ccfDNA and provided spectra of samples from different sources. Our findings introduce Raman spectroscopy as a new approach to implementing liquid biopsy diagnostics worthy of further elaboration.

摘要

循环游离 DNA(ccfDNA)是一种液体活检生物材料,因其在精准医疗诊断中的应用而受到广泛关注。对其结构和生物学的更深入了解将能够推动这些应用的发展。在这项研究中,我们采用拉曼光谱技术揭示了健康和疾病状态下人类 ccfDNA 的生物分子特征。我们建立了来自健康男性和女性(包括癌症和糖尿病患者)的 ccfDNA 样本的参考拉曼光谱,提取了有关其化学成分的信息。比较观察表明,接受新辅助治疗的乳腺癌患者的 ccfDNA 具有明显不同的光谱模式。对健康、糖尿病前期和糖尿病男性的 ccfDNA 的拉曼分析揭示了它们生物分子指纹之间的一些差异。我们还研究了来自人良性和癌细胞系的 ccfDNA,并将其与各自的 gDNA 进行了比较,证实其反映了其细胞来源。总的来说,我们首次在 ccfDNA 的研究中探索了拉曼光谱,并提供了来自不同来源的样本的光谱。我们的研究结果表明,拉曼光谱技术是一种有前途的液体活检诊断方法,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/5e2464989250/ijms-24-12384-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/5e4598dfa168/ijms-24-12384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/1449d38e746e/ijms-24-12384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/4bf44f1edc5e/ijms-24-12384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/f47ee1236917/ijms-24-12384-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/27b3a55af86a/ijms-24-12384-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/5e2464989250/ijms-24-12384-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/5e4598dfa168/ijms-24-12384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/1449d38e746e/ijms-24-12384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/4bf44f1edc5e/ijms-24-12384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/f47ee1236917/ijms-24-12384-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/27b3a55af86a/ijms-24-12384-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5657/10418917/5e2464989250/ijms-24-12384-g006.jpg

相似文献

1
Label-Free Human Disease Characterization through Circulating Cell-Free DNA Analysis Using Raman Spectroscopy.基于拉曼光谱的无标记循环游离 DNA 分析进行人类疾病特征分析。
Int J Mol Sci. 2023 Aug 3;24(15):12384. doi: 10.3390/ijms241512384.
2
Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.液体活检分析结直肠癌相关突变:循环无细胞 DNA 和循环肿瘤细胞的应用。
Cancer Sci. 2019 Nov;110(11):3497-3509. doi: 10.1111/cas.14186. Epub 2019 Sep 18.
3
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.转移性乳腺癌患者的临床结局与循环肿瘤细胞和循环游离 DNA 的关系。
Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.
4
Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT.接受新辅助化疗的乳腺癌患者血浆 ccfDNA、mtDNA 变化、CTC 与上皮间质转化的相关性。
Turk J Med Sci. 2024 Mar 11;54(4):652-665. doi: 10.55730/1300-0144.5834. eCollection 2024.
5
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.早期和晚期结肠癌及胰腺癌中循环游离DNA的突变模式
Cancer Genet. 2017 Dec;218-219:39-50. doi: 10.1016/j.cancergen.2017.08.006. Epub 2017 Sep 14.
6
Circulating cell-free DNA release in vitro: kinetics, size profiling, and cancer-related gene methylation.循环游离 DNA 体外释放:动力学、大小分析和与癌症相关的基因甲基化。
J Cell Physiol. 2019 Aug;234(8):14079-14089. doi: 10.1002/jcp.28097. Epub 2019 Jan 7.
7
Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.循环游离DNA完整性作为乳腺癌和前列腺癌的诊断及预后标志物
Cancer Genet. 2019 Jun;235-236:65-71. doi: 10.1016/j.cancergen.2019.04.062. Epub 2019 Apr 23.
8
Evaluation of circulating cell free DNA in plasma as a biomarker of different thyroid diseases.评估血浆中的循环无细胞 DNA 作为不同甲状腺疾病的生物标志物。
Braz J Otorhinolaryngol. 2020 May-Jun;86(3):321-326. doi: 10.1016/j.bjorl.2018.12.008. Epub 2019 Feb 18.
9
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.基于循环无细胞 DNA 的生物标志物用于预测和监测肾上腺皮质癌的疾病进展。
Eur J Endocrinol. 2024 Mar 2;190(3):234-247. doi: 10.1093/ejendo/lvae022.
10
Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson's Disease Patients.特发性帕金森病患者循环游离DNA的定量分析
Int J Mol Sci. 2024 Feb 29;25(5):2818. doi: 10.3390/ijms25052818.

引用本文的文献

1
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.BRCA1和BRCA2甲基化作为癌症的预后和预测生物标志物:在精准医学时代液体活检中的应用
Clin Epigenetics. 2024 Dec 6;16(1):178. doi: 10.1186/s13148-024-01787-8.

本文引用的文献

1
Circadian rhythm and circulating cell-free DNA release on healthy subjects.健康受试者的昼夜节律和循环游离 DNA 释放。
Sci Rep. 2023 Dec 7;13(1):21675. doi: 10.1038/s41598-023-47851-w.
2
Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy.利用共焦拉曼光谱技术对人体无创血糖测量的精确后校准预测。
ACS Sens. 2023 Mar 24;8(3):1272-1279. doi: 10.1021/acssensors.2c02756. Epub 2023 Mar 6.
3
Raman Spectroscopy for Chemical Biology Research.拉曼光谱在化学生物学研究中的应用。
J Am Chem Soc. 2022 Nov 2;144(43):19651-19667. doi: 10.1021/jacs.2c05359. Epub 2022 Oct 10.
4
Circulating tumor DNA: current challenges for clinical utility.循环肿瘤 DNA:临床应用的当前挑战。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI154941.
5
Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach.用于监测疾病的组织特异性甲基化生物标志物:一种计算方法。
Int J Mol Sci. 2022 Mar 9;23(6):2959. doi: 10.3390/ijms23062959.
6
Liquid Biopsy in Type 2 Diabetes Mellitus Management: Building Specific Biosignatures via Machine Learning.2型糖尿病管理中的液体活检:通过机器学习构建特定生物标志物
J Clin Med. 2022 Feb 17;11(4):1045. doi: 10.3390/jcm11041045.
7
Do Microplastics Enter Our Food Chain Via Root Vegetables? A Raman Based Spectroscopic Study on .微塑料会通过块根类蔬菜进入我们的食物链吗?一项基于拉曼光谱的研究……
Materials (Basel). 2021 Apr 30;14(9):2329. doi: 10.3390/ma14092329.
8
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden.组织特异性游离 DNA 降解定量检测循环肿瘤 DNA 负担。
Nat Commun. 2021 Apr 13;12(1):2229. doi: 10.1038/s41467-021-22463-y.
9
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine.乳腺癌中的循环游离DNA:探寻精准医学的隐藏信息
Cancers (Basel). 2021 Feb 10;13(4):728. doi: 10.3390/cancers13040728.
10
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond.基于血液的 ctDNA 分析的临床意义:突变检测及其他。
Br J Cancer. 2021 Jan;124(2):345-358. doi: 10.1038/s41416-020-01047-5. Epub 2020 Sep 24.